Tranexamic Acid
- Product NDC
- 63323-563
- 11-digit product format
- 633230563
- Labeler code
- 63323
- Product ID
- 63323-563_ddb5d068-9d9e-45da-92d7-516dd792af1b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tranexamic Acid
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA091596
- Marketing category
- ANDA
- Marketing start
- 2012-05-24
- Marketing end
- 0000-00-00
- Substance
- TRANEXAMIC ACID
- Active strength
- 100 mg/mL
- Pharmacologic classes
- Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63323-563 | TRANEXAMIC ACID INJECTION, SOLUTION [FRESENIUS KABI USA, LLC
] | 7 | Legacy NDC | 20220319_c6c3da51-fc45-4d5c-b983-1576830c95dd.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-563-10 | 63323056310 | 10 VIAL in 1 TRAY (63323-563-10) > 10 mL in 1 VIAL (63323-563-01) | 10 vial | 2012-05-24 | 0000-00-00 | No | No | Current |